(Q34259429)

1 August 2017

1 reference

title

Organ preservation for carcinoma of the larynx and hypopharynx (English)

1 reference

1 August 2017

0 references

Garden AS

1

1 reference

1 August 2017

publication date

1 April 2001

1 reference

Hematology / Oncology Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

243-60, v

1 reference

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Treatment of supraglottic cancer by radical high dose radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Hemilaryngectomy following radiation failure for carcinoma of the vocal cords

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Supraglottic laryngectomy: 30 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Treatment decisions in T3N0M0 glottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Quality of life and voice in patients with laryngeal carcinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Laryngectomy alone for T3 glottic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Cisplatin and radiotherapy in the management of locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T3 glottic cancer: an analysis of dose time-volume factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T4nomo glottic cancer: A analysis of dose-time volume factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Radiotherapy of early glottic cancer—I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Larynx Preservation Using Induction Chemotherapy plus Radiation Therapy as an Alternative to Laryngectomy in Advanced Head and Neck Cancer A Long-Term Follow-up Report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Prognostic factors in T3,N0-1 glottic and transglottic carcinoma. A multifactorial study of 221 cases treated by surgery or radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Supracricoid partial laryngectomy after failed laryngeal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Partial laryngectomy for glottic cancer after high-dose radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T3N0M0 glottic carcinoma--a failure analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

The Patterns of Care Outcome Studies: results of the National practice in carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Squamous cell carcinoma of the pyriform sinus treated with radical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Stage T3 squamous cell carcinoma of the glottic larynx: A comparison of laryngectomy and irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Transglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Controversies in the management of laryngeal cancer: results of an international survey of patterns of care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Randomized trial of induction chemotherapy in larynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Hydroxyurea and radiotherapy in head and neck cancer. Results of a prospective controlled study in 126 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Re-irradiation of laryngeal carcinoma--techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Treatment of carcinoma of the vocal cord a review of 20 years experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

Management of stage T3 and T4 glottic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970210-0

7 January 2021

10.1016/S0889-8588(05)70210-0

Identifiers

DOI

1 reference

1 August 2017

1 reference